Gherman C - Search Results

1

Pharmacokinetics Evaluation of Carbon Nanotubes Using FTIR Analysis and Histological Analysis.

Gherman C, Tudor MC, Constantin B, Flaviu T, Stefan R, Maria B, Chira S, Braicu C, Pop L, Petric RC, Berindan-Neagoe I. Gherman C, et al. J Nanosci Nanotechnol. 2015 Apr;15(4):2865-9. doi: 10.1166/jnn.2015.9845. J Nanosci Nanotechnol. 2015. PMID: 26353506

2

Epigallocatechin gallate induce cell death and apoptosis in triple negative breast cancer cells Hs578T.

Braicu C, Gherman C. Braicu C, et al. Among authors: gherman c. J Drug Target. 2013 Apr;21(3):250-256. doi: 10.3109/1061186X.2012.740673. Epub 2012 Nov 19. J Drug Target. 2013. PMID: 23163783

3

TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis.

Pileczki V, Braicu C, Gherman CD, Berindan-Neagoe I. Pileczki V, et al. Among authors: gherman cd. Int J Mol Sci. 2012 Dec 24;14(1):411-20. doi: 10.3390/ijms14010411. Int J Mol Sci. 2012. PMID: 23263670 Free PMC article.

4

Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells.

Braicu C, Gherman CD, Irimie A, Berindan-Neagoe I. Braicu C, et al. Among authors: gherman cd. J Nanosci Nanotechnol. 2013 Jan;13(1):632-7. doi: 10.1166/jnn.2013.6882. J Nanosci Nanotechnol. 2013. PMID: 23646788

5

Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells.

Irimie AI, Braicu C, Zanoaga O, Pileczki V, Gherman C, Berindan-Neagoe I, Campian RS. Irimie AI, et al. Among authors: gherman c. Onco Targets Ther. 2015 Feb 20;8:461-70. doi: 10.2147/OTT.S78358. eCollection 2015. Onco Targets Ther. 2015. PMID: 25759589 Free PMC article.

6

Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer.

Budisan L, Gulei D, Zanoaga OM, Irimie AI, Sergiu C, Braicu C, Gherman CD, Berindan-Neagoe I. Budisan L, et al. Among authors: gherman cd. Int J Mol Sci. 2017 Jun 1;18(6):1178. doi: 10.3390/ijms18061178. Int J Mol Sci. 2017. PMID: 28587155 Free PMC article. Review.

7

The new era of nanotechnology, an alternative to change cancer treatment.

Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I. Jurj A, et al. Among authors: gherman cd. Drug Des Devel Ther. 2017 Sep 27;11:2871-2890. doi: 10.2147/DDDT.S142337. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29033548 Free PMC article. Review.

8

Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells.

Tudoran O, Soritau O, Balacescu O, Balacescu L, Braicu C, Rus M, Gherman C, Virag P, Irimie F, Berindan-Neagoe I. Tudoran O, et al. Among authors: gherman c. J Cell Mol Med. 2012 Mar;16(3):520-30. doi: 10.1111/j.1582-4934.2011.01346.x. J Cell Mol Med. 2012. PMID: 21609393 Free PMC article.

9

Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis.

Gherman C, Braicu OL, Zanoaga O, Jurj A, Pileczki V, Maralani M, Drigla F, Braicu C, Budisan L, Achimas-Cadariu P, Berindan-Neagoe I. Gherman C, et al. Mol Cell Biochem. 2016 Feb;413(1-2):189-98. doi: 10.1007/s11010-015-2652-3. Epub 2016 Feb 2. Mol Cell Biochem. 2016. PMID: 26838168

10

Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients.

Balacescu O, Balacescu L, Virtic O, Visan S, Gherman C, Drigla F, Pop L, Bolba-Morar G, Lisencu C, Fetica B, Tudoran O, Berindan-Neagoe I. Balacescu O, et al. Among authors: gherman c. Mediators Inflamm. 2016;2016:3239167. doi: 10.1155/2016/3239167. Epub 2016 Jan 13. Mediators Inflamm. 2016. PMID: 26884644 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page